Ligand validation:8B1E

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 8B1E designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8B1E_LMT_A_801	11%	36%	0.286	0.804	1.16	1.34	3	4	3	0	100%	1
8B1J_LMT_A_801	18%	35%	0.273	0.858	1.19	1.36	2	4	3	0	100%	1
8B1I_LMT_A_801	15%	31%	0.232	0.793	1.25	1.48	2	9	3	0	100%	1
8B1A_LMT_A_801	15%	36%	0.232	0.791	1.18	1.32	2	4	2	0	100%	1
8B1F_LMT_A_801	10%	33%	0.288	0.8	1.22	1.41	4	6	10	0	100%	1
8B1G_LMT_A_801	9%	29%	0.354	0.852	1.18	1.63	3	10	2	0	100%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
7M78_LMT_L_202	95%	44%	0.073	0.976	1.13	1.04	3	2	0	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
3T2K_LMT_A_501	82%	32%	0.082	0.936	1.31	1.4	4	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.